Skip to content

Effectiveness of iPACK on Postoperative Pain From Hamstring Autograft Following ACL Repair

Effectiveness of Preoperative iPACK on Postoperative Pain From Hamstring Autograft for ACL Repair

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05080348
Enrollment
40
Registered
2021-10-15
Start date
2021-12-31
Completion date
2022-05-31
Last updated
2021-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injury, Anesthesia, Local, Opioid Use, Pain, Postoperative

Brief summary

Patients undergoing ACL repair with hamstring autograft frequently develop significant post operative pain at the hamstring grafting site. This pain is within the distribution of a commonly used regional nerve block, the Interspace between the popliteal artery and capsule of the knee (iPACK). The investigators plan to randomize consenting patients to either receiving a SHAM injection of normal saline or to an interventional group of long acting local anesthetic (Ropivacaine) injected in the popliteal fossa between the popliteal artery and capsule of the knee (iPACK). Both groups of patients will receive standard of care with respect to perioperative pain management, which includes a preoperative adductor canal nerve block and preoperative acetaminophen administration. Dual primary endpoints of postoperative pain scores and mean postoperative opioid use will be retrieved and compared between groups. Additional secondary endpoints will be PACU length of stay, PACU opioid use, POD1 opioids use, and POD1 pain scores (best, worst, average).

Interventions

PROCEDURERopivacaine iPACK Injection

Injection of 20mL of 0.25% Ropivacaine with 1:400,000 Epinephrine between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles

PROCEDURENormal Saline iPACK Injection

Injection of 20mL of 0.9% Normal Saline between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles

Sponsors

Brenton Alexander
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

The patient will not know which group they are in as they will be injected with either SHAM or Intervention group, which the pharmacy will create. As a result, the anesthesiologist performing the injection and the intraoperative anesthesiologist will also not know if the patient received a SHAM or intervention injection. This will also apply to the PACU nurse. The person performing the data analysis will know which patients received the intervention, as this is required for data analysis.

Intervention model description

Randomized double blind placebo controlled

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoing ACL surgery with expected Hamstring Autograft by Dr. Catherine Robertson at UC San Diego * At least 18 years of age * Able to Provide Consent in English prior to Surgery

Exclusion criteria

* Pregnancy (a urine pregnancy test is standard at UCSD for female patients prior to menopause who are sexually active with the opposite sex within the previous year) * Inability to communicate with the investigators and hospital staff * Severe renal, hepatic or cardiac disease * Chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone) * BMI \> 45 kg/m2 * Allergy to study medications (lidocaine, bupivacaine) * Incarceration.

Design outcomes

Primary

MeasureTime frameDescription
Median Post Anesthesia Recovery Unit (PACU) Pain ScoreFrom arrival in PACU until patient has been cleared for PACU dischargeMedian pain score collected in the PACU following surgery on a scale of 1-10 (1 being no pain, 10 being the worst pain the patient has ever experienced)
Total Perioperative Opioid Use (Morphine equivalents)From time of the start of surgery until time that patient meets PACU discharge criteriaIntraoperative and Post Operative (in the PACU) opioid use

Secondary

MeasureTime frameDescription
PACU Length of Stay (days)From PACU arrival until criteria for PACU discharge are metLength of stay from PACU arrival to ready for discharge criteria are met
PACU Opioid Use (Morphine equivalents)From PACU arrival until criteria for PACU discharge are metAll opioid use in the PACU
Postoperative Day (POD) 1 Opioid Use (Morphine Equivalents)Time of discharge from PACU until 24 hours after PACU dischargeAll Opioid use in the approximate 24 hours following PACU Discharge
Best, Worst, Average Pain Scores on POD 1For the entire length of post operative day 1Best, Worst and Average pain scores collected on POD 1 following surgery on a scale of 1-10 (1 being no pain, 10 being the worst pain the patient has ever experienced)

Contacts

Primary ContactBrenton Alexander, MD
bsalexander@health.ucsd.edu(858) 657-7000
Backup ContactRodney Gabriel, MD, MAS
ragabriel@ucsd.edu(858) 657-7000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026